My view on what the next six quarters may look until we hit the break even target in Q4 CY 2018.
Have assumed linear growth of ADAPT revenue as I don't have sufficient detail to phase it any differently.
As you can see I believe we need between $11 and $12M in quarterly revenue to break even.
As expected the losses quickly reduce as ADAPT becomes a bigger and bigger piece of the pie.
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 0 CY2017 CY2017 CY2018 CY2018 CY2018 CY2018 Assumptions 1 Revenue ($M)[/B] Q3 Q4 Q1 Q2 Q3 Q4 2 Infusion 3.5 3.5 3.5 3.5 3.5 3.5 $14M annual 3 ADAPT 3 4 5 6 7 8 4 5 Total Revenue 6.5 7.5 8.5 9.5 10.5 11.5 6 7 Margin 8 Infusion 1.8 1.8 1.8 1.8 1.8 1.8 50% 9 ADAPT 2.1 2.8 3.5 4.2 4.9 5.6 70% 10 11 Total Margin 3.9 4.6 5.3 6.0 6.7 7.4 12 13 SG&A 6.8 6.8 6.8 6.8 6.8 6.8 $27M annual spend 14 15 Profit/(loss) (2.9) (2.2) (1.5) (0.8) (0.1) 0.6
Obviously just my opinion DYOR
- Forums
- ASX - By Stock
- Ann: Investor Webinar Presentation
My view on what the next six quarters may look until we hit the...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$12.56 |
Change
-0.740(5.56%) |
Mkt cap ! $265.4M |
Open | High | Low | Value | Volume |
$13.06 | $13.30 | $12.55 | $359.0K | 27.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 399 | $12.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.78 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 399 | 12.560 |
1 | 722 | 12.550 |
2 | 216 | 12.500 |
1 | 80 | 12.400 |
1 | 50 | 12.350 |
Price($) | Vol. | No. |
---|---|---|
12.780 | 500 | 1 |
12.800 | 712 | 2 |
13.000 | 1793 | 3 |
13.250 | 1000 | 1 |
13.300 | 3 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |